3.6 Phase II Grant Application Document

Tree Star's SBIR Phase II application entitled "Clinical Cytometry Analysis Software with Automated Gating" has been received by the National Institutes of Health and assigned to a Scientific Review Group (SRG) for scientific merit evaluation and to an Institute/Center for funding consideration.

The initial peer review should be completed by the end of March 2010 and a funding decision made
shortly after the appropriate National Advisory Group meets in May 2010.

3.6.1 Preliminary Studies - Progress Report

3.6.2 Research Design and Methods

3.6.3 Specific Aims - Objectives

3.6.4 Abstract

3.6.5 Animal Subjects

All necessary protocols and approvals are on file with the cooperating laboratories where our data was collected. Tree Star will receive representative data generated by laboratory studies and collected before the commencement of this grant. This is also true of the human data the study uses.

3.6.6 Background/Significance

3.6.7 Budget Justification

3.6.8 Commercialization

3.6.9 Datasharing

3.6.10 Facilities

Tree Star's collaborating sites are engaged in their own research but will not be performing research on our behalf. Rather they will supply us with ancillary data collected pursuant to their research goals. Tree Star anticipates their help in testing pre-release versions of our new software.
Collaborating sites include:

Division of Viral Pathogenesis, Department of Medicine at Beth Israel Deaconess Medical Center, Boston, Massachusetts.
Terry Fox Laboratory, BC Cancer Research Centre, Vancouver, British Columbia, Canada

3.6.11 Funds Spent Abroad

3.6.12 Human Subjects

3.6.13 Inclusion of Children:

Data from children will not be collected. There are no children among the potential subjects, which are cytometer operators, technicians, and analysts.

3.6.14 Narrative

3.6.15 Women and Minorities

5.1 References